Technology promotion, the pathophysiological role of JunB/AP-1 in mylom (Q3061538)
Jump to navigation
Jump to search
Project Q3061538 in Austria
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Technology promotion, the pathophysiological role of JunB/AP-1 in mylom |
Project Q3061538 in Austria |
Statements
248,550.0 Euro
0 references
1 October 2018
0 references
30 September 2021
0 references
Karl Landsteiner Privatuniversität für Gesundheitswissenschaften GmbH
0 references
48°24'35.32"N, 15°36'22.75"E
0 references
30101
0 references
Pathophysiological Role of JunB/AP-1 in Mulitiplene Mylom – Basis for Innovative Drug Development (English)
20 July 2021
0.0003327186477377
0 references
Rôle pathophysiologique de JunB/AP-1 dans le Mylome Mulitiplen — Base pour le développement de médicaments innovants (French)
27 November 2021
0 references
Pathofysiologische rol van JunB/AP-1 in Mulitiplen Mylom — basis voor innovatieve ontwikkeling van geneesmiddelen (Dutch)
29 November 2021
0 references
Pathophysiologische Rolle von JunB/AP-1 im Mulitiplen Mylom - Grundlage für eine innovative Medikamenten-Entwicklung (German)
0 references
Ruolo patofisiologico di JunB/AP-1 in Mulitiplen Mylom — base per lo sviluppo innovativo dei farmaci (Italian)
11 January 2022
0 references
Papel patofisiológico de JunB/AP-1 en Mulitiplen Mylom — base para el desarrollo innovador de fármacos (Spanish)
12 January 2022
0 references
Παθοφυσιολογικός ρόλος του JunB/AP-1 στο Mulitiplene Mylom — Βάση για την Καινοτόμη Ανάπτυξη Ναρκωτικών (Greek)
17 August 2022
0 references
JunB/AP-1's patofysiologiske rolle i Mulitiplene Mylom — Grundlaget for innovativ lægemiddeludvikling (Danish)
17 August 2022
0 references
JunB/AP-1:n patofysiologinen rooli Mulitiplene Mylomissa – Innovatiivisen lääkekehityksen perusta (Finnish)
17 August 2022
0 references
Ir-Rwol patofiżjoloġiku ta’ JunB/AP-1 f’Milom ta’ Mulitiplene — Bażi għall-Iżvilupp Innovattiv tal-Mediċina (Maltese)
17 August 2022
0 references
JunB/AP-1 patofizioloģiskā loma Mulitiplene Mylom — pamats novatorisku zāļu attīstībai (Latvian)
17 August 2022
0 references
Patofyziologická úloha JunB/AP-1 v Mulitiplene Mylom – základ pre inovačný vývoj liekov (Slovak)
17 August 2022
0 references
Ról Patophysiological Junb/AP-1 i Mulitiplene Mylom — Bunús d’Fhorbairt Drugaí Nuálacha (Irish)
17 August 2022
0 references
Patofyziologická role JunB/AP-1 v Mulitiplene Mylom – základ pro inovativní vývoj léčiv (Czech)
17 August 2022
0 references
Papel fisiopatológico do JunB/AP-1 no Mulitiplene Mylom — Base para o Desenvolvimento Inovador de Drogas (Portuguese)
17 August 2022
0 references
JunB/AP-1 patofüsioloogiline roll Mulitiplene Mylomis – Uuendusliku narkootikumide arendamise alus (Estonian)
17 August 2022
0 references
A JunB/AP-1 patofiziológiai szerepe a Mulitiplene Mylomban – Az innovatív gyógyszerfejlesztés alapja (Hungarian)
17 August 2022
0 references
Патофизиологична роля на JunB/AP-1 в Mulitiplene Mylom — База за иновативно разработване на лекарства (Bulgarian)
17 August 2022
0 references
Patofiziologinis JunB/AP-1 vaidmuo Mulitiplene Mylom – Naujoviškos narkotikų plėtros pagrindas (Lithuanian)
17 August 2022
0 references
Patofiziološka uloga JunB/AP-1 u milomu mulitiplene – Osnova za inovativni razvoj lijekova (Croatian)
17 August 2022
0 references
Patofysiologisk roll för JunB/AP-1 i Mulitiplene Mylom – Grund för innovativ läkemedelsutveckling (Swedish)
17 August 2022
0 references
Rolul fiziopatologic al JunB/AP-1 în Mulitiplene Mylom – Baza pentru dezvoltarea inovatoare a medicamentelor (Romanian)
17 August 2022
0 references
Patofiziološka vloga JunB/AP-1 v Mulitiplenu Mylom – Podlaga za razvoj inovativnih zdravil (Slovenian)
17 August 2022
0 references
Patofizjologiczna rola JunB/AP-1 w Mulitiplene Mylom – Podstawa rozwoju innowacyjnych leków (Polish)
17 August 2022
0 references
Krems an der Donau
0 references
Identifiers
AUST-1250
0 references